Industry & ResearchNews
Nanopatch sparks interest at med-tech conference
An innovative project that will change the way vaccines are delivered to patients sparked the most interest at the AusMedtech conference and investment summit in Sydney. The Vaxxas Nonopatch developed by the University of Queensland is expected to reduce production and storage costs.
Please login below to view content or subscribe now.
